Impact of Nitrate Ingestion on Protein Synthesis
PRO-Nitrate
The Impact of Dietary Nitrate Ingestion on Muscle Protein Synthesis in Elderly Type II Diabetics
1 other identifier
interventional
25
1 country
1
Brief Summary
A diet rich in leafy green vegetables has been shown to reduce the risk of developing chronic metabolic disease. The health benefits from these particular vegetables may be attributed to their high nitrate content. Recent work suggests that dietary nitrate triggers endogenous nitric oxide release, thereby stimulating vasodilation and improving muscle perfusion in an insulin-independent manner. We hypothesize that in an insulin-resistant state, nitrate co-ingestion will increase muscle perfusion, thereby improving post-prandial delivery of nutrients to skeletal muscle tissue. Specifically, a more efficient delivery of food derived amino acids will stimulate post-prandial muscle protein synthesis and, as such, compensate for a blunted muscle protein synthetic response to food intake in the elderly. This proposal will investigate the efficacy of nitrate co-ingestion as a means to augment muscle protein synthesis in elderly, type 2 diabetes patients and may lead to a novel therapy in the clinical care of type 2 diabetes patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Aug 2011
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2011
CompletedFirst Submitted
Initial submission to the registry
November 3, 2011
CompletedFirst Posted
Study publicly available on registry
November 17, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2013
CompletedApril 15, 2016
October 1, 2012
11 months
November 3, 2011
April 14, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Muscle protein fractional synthetic rate
Muscle protein fractional synthetic rate assessed using the muscle biopsy technique.
-2, 0, +2, +5 h during the trial
Secondary Outcomes (2)
Plasma amino acids
every 30 min (from -2 h to + 5 h during the test day)
Plasma nitrate
every 30 min (from -2 h to + 5 h during the test day)
Study Arms (2)
Nitrate
EXPERIMENTALSodium nitrate ingestion prior to ingesting intrinsically labeled protein
Sodium chloride
PLACEBO COMPARATORSodium chloride placebo group
Interventions
0.15 mmol sodium chloride dissolved in 250 mL water.
Eligibility Criteria
You may qualify if:
- Male
- Aged between 70-85 years
- BMI \< 30 kg/m2
- Non insulin-dependent diabetes mellitus type 2 patients (T2DM) ( \>1 y since diagnoses)
You may not qualify if:
- Smoking
- Hypertension (according to WHO criteria)\[29\] and/or cardiovascular disease treated with medication containing nitrates and/or having vasodilatory effects
- Use of medication, except for oral blood glucose lowering medication
- Use of insulin
- All co-morbidities interacting with mobility and muscle metabolism of the lower limbs (e.g. arthritis, spasticity/rigidity, all neurological disorders and paralysis).
- HbA1c \> 10.0% (86 mmol/mol)
- Donated blood in last 3 months
- Diagnosed impaired renal or liver function
- Myocardial infarction within the last 3 years
- Gastric acid inhibitors
- Use of anti-coagulants
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Maastricht University
Maastricht, Limburg, 6229ER, Netherlands
Related Publications (2)
Gorissen SHM, Trommelen J, Kouw IWK, Holwerda AM, Pennings B, Groen BBL, Wall BT, Churchward-Venne TA, Horstman AMH, Koopman R, Burd NA, Fuchs CJ, Dirks ML, Res PT, Senden JMG, Steijns JMJM, de Groot LCPGM, Verdijk LB, van Loon LJC. Protein Type, Protein Dose, and Age Modulate Dietary Protein Digestion and Phenylalanine Absorption Kinetics and Plasma Phenylalanine Availability in Humans. J Nutr. 2020 Aug 1;150(8):2041-2050. doi: 10.1093/jn/nxaa024.
PMID: 32069356DERIVEDKouw IW, Gorissen SH, Burd NA, Cermak NM, Gijsen AP, van Kranenburg J, van Loon LJ. Postprandial Protein Handling Is Not Impaired in Type 2 Diabetes Patients When Compared With Normoglycemic Controls. J Clin Endocrinol Metab. 2015 Aug;100(8):3103-11. doi: 10.1210/jc.2015-1234. Epub 2015 Jun 2.
PMID: 26037513DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Luc van Loon, PhD
Maastricht University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 3, 2011
First Posted
November 17, 2011
Study Start
August 1, 2011
Primary Completion
July 1, 2012
Study Completion
December 1, 2013
Last Updated
April 15, 2016
Record last verified: 2012-10
Data Sharing
- IPD Sharing
- Will not share